Stockscreener 앱 받기
3.68
1.66%
0.06
시간 외 거래:
3.68
전일 마감가:
$3.62
열려 있는:
$3.65
하루 거래량:
81,827
Relative Volume:
1.15
시가총액:
$58.50M
수익:
-
순이익/손실:
$-23.87M
주가수익비율:
-0.1871
EPS:
-19.67
순현금흐름:
$-47.63M
1주 성능:
+1.10%
1개월 성능:
+6.98%
6개월 성능:
+32.37%
1년 성능:
+1.94%
1일 변동 폭
$3.615
$3.74
1주일 범위
$3.50
$3.74
52주 변동 폭
$2.30
$3.93
폴리피드 Stock (PYPD) Company Profile
PYPD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.68 | 60.22M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
폴리피드 Stock (PYPD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-05 | 개시 | Roth Capital | Buy |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-09-14 | 개시 | JMP Securities | Mkt Outperform |
| 2021-07-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | 개시 | Alliance Global Partners | Buy |
| 2020-07-21 | 개시 | BMO Capital Markets | Outperform |
| 2020-07-21 | 개시 | Barclays | Overweight |
| 2020-07-21 | 개시 | Raymond James | Outperform |
모두보기
폴리피드 주식(PYPD)의 최신 뉴스
PolyPid Ltd. to Host Virtual KOL Event on D-PLEX100 and Surgical Site Infection Prevention - Quiver Quantitative
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 - GlobeNewswire
How analysts rate PolyPid Ltd. stock todayJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com
What makes PolyPid Ltd. stock attractive to growth fundsJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Top chart patterns to watch in PolyPid Ltd.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
PolyPid price target lowered to $9 from $10 at Roth Capital - MSN
Published on: 2025-11-19 04:16:34 - newser.com
Will PolyPid Ltd. stock outperform growth indexesJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Will PolyPid Ltd. rebound enough to break evenInsider Selling & Intraday High Probability Alerts - newser.com
Why PolyPid Ltd. stock could benefit from AI revolutionMarket Movement Recap & Risk Controlled Swing Trade Alerts - newser.com
What analysts say about PolyPid Ltd stockLong-Term Growth Stocks & Start Small. End Wealthy. - earlytimes.in
Roth Capital Issues Optimistic Estimate for PolyPid Earnings - Defense World
Published on: 2025-11-16 12:50:26 - newser.com
Wall Street Zen Upgrades PolyPid (NASDAQ:PYPD) to Hold - Defense World
PolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness - MSN
Using flow based indicators on PolyPid Ltd.July 2025 Summary & Proven Capital Preservation Methods - newser.com
Published on: 2025-11-13 18:14:47 - newser.com
Roth Capital Maintains PolyPid (PYPD) Buy Recommendation - Nasdaq
Is PolyPid Ltd. stock undervalued vs historical averagesJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
PolyPid (PYPD) Sees Price Target Cut by Roth Capital | PYPD Stoc - GuruFocus
PolyPid Ltd. (NASDAQ:PYPD) Q3 2025 Earnings Call Transcript - Insider Monkey
PolyPid Ltd. Advances Towards Key Milestones in 2025 - TipRanks
Published on: 2025-11-12 21:51:34 - newser.com
Leading vs lagging indicators on PolyPid Ltd. performanceOptions Play & Free Growth Oriented Trading Recommendations - newser.com
PolyPid Ltd. Earnings Call: Progress and Potential - TipRanks
PolyPid Ltd (PYPD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: PolyPid Q3 2025 shows mixed results, stock dips - Investing.com Australia
Transcript : PolyPid Ltd., Q3 2025 Earnings Call, Nov 12, 2025 - MarketScreener
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
PolyPid : Investor Presentation (29305a) - MarketScreener
PolyPid Keeps Moving Forward Despite Quarterly Losses - Finimize
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results - The Manila Times
PolyPid Ltd. Advances Regulatory Strategy with FDA Pre-NDA Meeting and U.S. Partnership Discussions Following Positive Phase 3 Trial Results - Quiver Quantitative
Biopharma firm PolyPid's Q3 net loss narrows to $7.5 mln - MarketScreener
[6-K] PolyPid Ltd. Current Report (Foreign Issuer) | PYPD SEC FilingForm 6-K - Stock Titan
PolyPid (NASDAQ: PYPD) completes IMOH GMP inspection; FDA pre‑NDA set, NDA in 2026 - Stock Titan
PolyPid receives Nasdaq’s non-compliance letter - MSN
Why PolyPid Ltd. stock could rally in 20252025 Market Sentiment & Free Real-Time Market Sentiment Alerts - newser.com
폴리피드 (PYPD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.88%
자본화:
|
볼륨(24시간):